Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study-Reference-Cited by-同舟云学术

Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study

Published:2019-04 Issue:4 Volume:20 Page:546-555
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Chae Sun Young,Ahn Sei Hyun,Kim Sung-Bae,Han Sangwon,Lee Suk Hyun,Oh Seung Jun,Lee Sang Ju,Kim Hee Jeong,Ko Beom Seok,Lee Jong Won,Son Byung Ho,Kim Jisun,Ahn Jin-Hee,Jung Kyung Hae,Kim Jeong Eun,Kim Seog-Young,Choi Woo Jung,Shin Hee Jung,Gong Gyungyub,Lee Hyo Sang,Lee Jung Bok,Moon Dae Hyuk

Funder

Ministry of Health and Welfare, South Korea

Publisher

Elsevier BV

Subject

Oncology

Reference36 articles.

1. Breast cancer statistics, 2017, racial disparity in mortality by state;DeSantis;CA Cancer J Clin,2017

2. A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases;Aurilio;Eur J Cancer,2014

3. Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature;Arslan;Expert Opin Ther Targets,2011

4. PET imaging of oestrogen receptors in patients with breast cancer;van Kruchten;Lancet Oncol,2013

5. 18F-Fluoroestradiol PET: current status and potential future clinical applications;Liao;J Nucl Med,2016

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 16α-¹⁸F-Fluoro-17β-Estradiol PET/CT—A Tool for Staging Estrogen Receptor–Expressing Breast Cancer?;JAMA Network Open;2024-07-26

2. PFKFB3 regulates breast cancer tumorigenesis and Fulvestrant sensitivity by affecting ERα stability;Cellular Signalling;2024-07

3. Characterization of an Estrogen Receptor α-Selective 18F-Estradiol PET Tracer;World Journal of Nuclear Medicine;2024-06-18

4. Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET;Annals of Oncology;2024-06

5. Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US;PLOS ONE;2024-05-14